ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,459.10
      1.11%
      US Tech 100
      18,522.40
      1.05%
      Dow Jones
      40,589.34
      1.64%
      Brent Oil
      79.745
      0.00%
      Bitcoin
      67,902.13
      -0.02%
      Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Redhill Biopharma Ltd (RDHL)

      7. Redhill Biopharma Ltd (RDHL) Financials

      Redhill Biopharma Ltd

      Redhill Biopharma Ltd (RDHL)

      NASDAQ
      0.3968
      0.0168
      (4.42%)
      Closed July 26 4:00PM
      Delayed by 15 minutes
      0.3985
      0.0017
      (0.43%)
      After Hours: 7:02PM
      Delayed by 15 minutes

      Redhill Biopharma Ltd Financial Summary

      The current RDHL market cap is 12.7M. The company's latest EPS is USD and P/E is N/A.

      Income Statement

      Annual Quarterly
      Quarter End Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Revenue 13.21M17.55M12.8M42.68M5.71M
      Operating Income -12.55M-7.11M-9.95M29.08M-4.41M
      Net Income -15.1M-35.7M-3.73M50.24M761k
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Revenue 6.29M64.36M85.76M61.8M50.59M
      Operating Income -43.2M-63.68M-81.14M-42.84M12.63M
      Net Income -42.3M-76.17M-97.74M-71.67M23.92M

      Balance Sheet

      Annual Quarterly
      Quarter End Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Assets 167.97M157.19M158.87M58.83M35.04M
      Total Liabilities 179.91M203.22M207.27M56.83M31.57M
      Total Equity -11.94M-46.03M-48.4M2M3.47M
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Assets 74.1M180.24M181.19M158.87M23.05M
      Total Liabilities 14.1M166.38M172.31M207.27M20.98M
      Total Equity 60M13.86M8.88M-48.4M2.07M

      Cash Flow

      Annual Quarterly
      Quarter End Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Operating -20.74M-26.76M-29.19M-7.19M-17.78M
      Investing 8.32M8.3M8.3M N/A -7k
      Financing 9.97M4.25M11.45M4.81M4.81M
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Operating -40.75M-48.58M-65.05M-29.19M-35.82M
      Investing 5.16M-35.65M-8.14M8.3M4k
      Financing 35.51M84.37M73.46M11.45M21.44M

      Stats and Ratios

      Market Cap 12.7M
      Price to Earnings Ratio N/A
      Price to Sales Ratio 0
      Price to Cash Ratio 0
      Price to Book Ratio 0
      Dividend Yield -

      Share Statistics

      Shares Outstanding 31.87M
      Average Volume (1 week) 0
      Average Volume (1 Month) 0
      52 Week Change -
      52 Week High -
      52 Week Low -
      Spread (Intraday) 0.05 (12.17%)

      Company Info

      Company Name Redhill Biopharma Ltd
      Address 21 ha’arba’a street
      tel aviv, center 64739
      Website https://www.redhillbio.com
      Industry pharmaceutical preparations (2834)